Clawback fee's upward revision means serious compromise of patients' access to medicines

The upward revision of the clawback tax as a result of the requests of the European Commission represents a real tragedy for Romanian patients and a major risk for the future of the pharmaceutical industry in Romania, said on Tuesday the Industrial Manufacturers of Medicines in Romania Employers association, PRIMER."PRIMER appeals to the prime minister Nicolae Ciuca and the minister of Health, Alexandru Rafila, to approach the request of the European Commission ...

Developed by Codecraftsman